Charles S. Sweet

A new class of angiotensin-converting enzyme inhibitors

Arthur A. Patchett, Elbert E. Harris, Edward W. Tristram et al. · Nature · 1980 · 706 citations

Medicine, Medicinal Chemistry, Pharmacology +8

Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipne ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension

Allan I. Goldberg, Charles S. Sweet · The American Journal of Cardiology · 1995 · 275 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

A Randomized, Placebo-Controlled, Double-Blind, Parallel Study of Various Doses of Losartan Potassium Compared With Enalapril Maleate in Patients With Essential Hypertension

Alan H. Gradman, Karen E. Arcuri, Allan I. Goldberg et al. · Hypertension · 1995 · 226 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.

Dennis M. Gross, Charles S. Sweet, E H Ulm et al. · Journal of Pharmacology and Experimental Therapeutics · 1981 · 150 citations

Medicine, Medicinal Chemistry, Pharmacology +8

Effects of Losartan on a Background of Hydrochlorothiazide in Patients With Hypertension

Beth A. Soffer, Jackson T. Wright, J. Howard Pratt et al. · Hypertension · 1995 · 140 citations

Pharmacy, Pharmacology, Cardiovascular Pharmacotherapy +13